Follow
Christopher L. Cummings
Title
Cited by
Cited by
Year
Comparative, collaborative, and integrative risk governance for emerging technologies
I Linkov, BD Trump, E Anklam, D Berube, P Boisseasu, C Cummings, ...
Environment Systems and Decisions 38 (2), 170-176, 2018
732018
Project on emerging nanotechnologies-consumer product inventory evaluated
DM Berube, EM Searson, TS Morton, CL Cummings
Nanotech. L. & Bus. 7, 152, 2010
582010
Investigating factors influencing consumer willingness to buy GM food and nano-food
C Yue, S Zhao, C Cummings, J Kuzma
Journal of Nanoparticle Research 17, 283, 2015
472015
A decision analytic model to guide early‐stage government regulatory action: Applications for synthetic biology
B Trump, C Cummings, J Kuzma, I Linkov
Regulation & Governance 12 (1), 88-100, 2018
432018
Societal Risk Evaluation Scheme (SRES): Scenario-Based Multi-Criteria Evaluation of Synthetic Biology Applications
K Cummings
PLOS ONE, http://dx.doi.org/10.1371/journal.pone.0, 2017
412017
Comparing nanoparticle risk perceptions to other known EHS risks
DM Berube, CL Cummings, JH Frith, AR Binder, R Oldendick
Journal of Nanoparticle Research 13 (8), 3089-3099, 2011
322011
Public Perceptions of Climate Geoengineering: A Systematic Review of the Literature
C Cummings, B Lin, Sapphire, Trump
Climate Research, 2017
312017
Influences of individual-level characteristics on risk perceptions to various categories of environmental health and safety risks
CL Cummings, DM Berube, ME Lavelle
Journal of Risk Research 16 (10), 1277-1295, 2013
312013
Cross-Sectional Design
C Cummings
The SAGE Encyclopedia of Communication Research Methods., 314-317, 2017
292017
Label it or ban it? Public perceptions of nano-food labels and propositions for banning nano-food applications
ASF Chuah, AD Leong, CL Cummings, SS Ho
Journal of Nanoparticle Research 20 (2), 1-17, 2018
242018
Communicating risk in the 21st century: The case of nanotechnology
DM Berube, B Faber, DA Scheufele, CL Cummings, GE Gardner, ...
National Nanotechnology Coordination Office, Arlington, 2010
242010
Characteristics and classification of nanoparticles: expert Delphi survey
D Berube, C Cummings, M Cacciatore, D Scheufele, J Kalin
Nanotoxicology 5 (2), 236-243, 2011
232011
Secondary Risk Theory: Validation of a Novel Model of Protection Motivation
CL Cummings, S Rosenthal, WY Kong
Risk Analysis, 2020
212020
Synthetic Biology 2020: Frontiers in Risk Analysis and Governance
BD Trump, C Cummings, J Kuzma, I Linkov
182020
Climate change and technology: examining opinion formation of geoengineering
CL Cummings, S Rosenthal
Environment Systems and Decisions 38 (2), 208-215, 2018
122018
The multi-facets of sustainable nanotechnology – Lessons from a nanosafety symposium
KWN Saji George, Shirley S. Ho, Esther S. P. Wong, Timothy Thatt Yang Tan ...
Nanotoxicology 9 (3), 404-406, 2015
122015
“Influenza” versus “Flu”: Do Different Medical Terms Affect Vaccination Intention?
CL Cummings, WY Kong
Journal of Health Communication, 2019
112019
Protection Motivation and Communication through Nanofood Labels: Improving Predictive Capabilities of Attitudes and Purchase Intentions toward Nanofoods
S Cummings, C. L., Chuah, A. G. S., and Ho
Science, Technology, & Human Values, 1-29, 2018
11*2018
Influence of rapid COVID-19 vaccine development on vaccine hesitancy
S Rosenthal, CL Cummings
Vaccine 39 (52), 7625-7632, 2021
102021
Synthetic biology: perspectives on risk analysis, governance, communication, and ELSI
BD Trump, CL Cummings, SE Galaitsi, J Kuzma, I Linkov
Synthetic Biology 2020: Frontiers in Risk Analysis and Governance, 1-18, 2020
102020
The system can't perform the operation now. Try again later.
Articles 1–20